BioChangeBioChange
BioChange

BioChange

Develops an injectable scaffold for tissue regeneration and repair.

2017Active17

About

BioChange harnesses the body's natural healing capabilities with its core CellFoam™ technology, a biodegradable and biocompatible foam scaffold designed to support complex tissue repair. The company offers products for both human and veterinary markets, aiming to enhance natural tissue regeneration for applications in dental, aesthetic, and neurological health, as well as veterinary medicine. BioChange's platform technology is scalable, affordable, and designed to facilitate multi-organ repair.

Technology stack

detected 2026-06-19
Est. monthly stack spend~$260/mo
EmailGoogle Workspace
Hosting
self_managed
Stack
jQueryWordPress
Analytics
Google Tag ManagerMeta Pixel
SEO
Yoast SEO
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does BioChange do?

BioChange harnesses the body's natural healing capabilities with its core CellFoam™ technology, a biodegradable and biocompatible foam scaffold designed to support complex tissue repair. The company offers products for both human and veterinary markets, aiming to enhance natural tissue regeneration for applications in dental, aesthetic, and neurological health, as well as veterinary medicine. BioChange's platform technology is scalable, affordable, and designed to facilitate multi-organ repair.

Where is BioChange headquartered?

BioChange is headquartered in Tel Aviv, Israel.

When was BioChange founded?

BioChange was founded in 2017.

What industry does BioChange operate in?

BioChange operates in Dermatology, Healthcare, Biotech, MedTech, HealthTech, Tissue Regeneration.

How many employees does BioChange have?

BioChange has approximately 17 people on record.